Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.

Author: JakobsenStine Mjåvatn, KerstenHege, MoldenEspen

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To compare the brain anticholinergic activities of five urinary spasmolytic drugs (USDs). DESIGN: In vitro study. SETTING: Laboratory. PARTICIPANTS: None. MEASUREMENTS: A validated 96-well anticholinergic radio receptor bioassay using small incubation volumes (240 μL per well) was ap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1532-5415.2010.03307.x

データ提供:米国国立医学図書館(NLM)

Brain Anticholinergic Activities of Urinary Spasmolytic Drugs: A Comparative Study

Urinary spasmolytic drugs are commonly used to treat urinary incontinence. This research investigates the brain anticholinergic activities of five different urinary spasmolytic drugs: tolterodine, oxybutynin, solifenacin, darifenacin, and 5-hydroxy-methyl-tolterodine (5-HMT). The study utilized a high-throughput radio receptor bioassay to assess the anticholinergic potency of these drugs in the brain.

Anticholinergic Activity: A Potential for Cognitive Side Effects

The study found that tolterodine and 5-HMT exhibited the highest brain anticholinergic activity, suggesting a potential for cognitive side effects, particularly in older adults. It's like encountering a mirage in the desert - a tempting but illusory vision. The study highlights the importance of considering the potential for central anticholinergic side effects when prescribing these drugs.

Considerations for Patient Safety

The research underscores the need for careful consideration of individual patient factors, particularly age and cognitive function, when prescribing urinary spasmolytic drugs. It's a reminder that just as the desert can be unforgiving, medications can have unintended consequences. Healthcare professionals should weigh the potential benefits and risks of these drugs, particularly for individuals at risk of cognitive impairment.

Dr.Camel's Conclusion

This research sheds light on the complex interplay between medications and the brain. It's a reminder that just as the desert holds secrets waiting to be unraveled, the world of medicine continues to explore the intricate relationships between drugs and the human body. The study emphasizes the importance of understanding the potential for central anticholinergic side effects, particularly in vulnerable populations, and highlights the need for careful prescribing practices to ensure patient safety.

Date :
  1. Date Completed 2011-06-02
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

21391941

DOI: Digital Object Identifier

10.1111/j.1532-5415.2010.03307.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.